Export/share
Export/share
Hofmarcher, Maria M. and Röhrling, Gerald (2003) Health Policy Monitor, Pharmaceutical Price Policy. Bertelsmann Stiftung, Health Policy Monitor 2003 (2), 7 p.
|
Text
oa42.pdf - Published Version Download (36kB) | Preview |
Official URL: http://www.hpm.org/en/index.html
Abstract
The two main reasons for a future cost increase in the pharmaceutical sector in Austria are the demographic development and medical progress.In order to contain cost increases the policy purses two objectives: Introduction of a new price formation procedure and increased generic consumption to 20% of all prescribed drugs by 2006.
| Item Type: | Discussion/ Working Paper (Unspecified) |
|---|---|
| Keywords: | Pharmaceutical Policy |
| Date Deposited: | 06 Oct 2016 09:53 |
| Last Modified: | 23 Feb 2017 12:25 |
| URI: | https://irihs.ihs.ac.at/id/eprint/4075 |
Actions (login required)
 |
View Item |